Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

J. K. Overbeek, R. ter Heine, H. M.W. Verheul, E. Chatelut, M. A. Rudek, H. Gurney, R. Plummer, D. C. Gilbert, T. Buclin, D. M. Burger, H. J. Bloemendal, N. P. van Erp

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Article number100749
JournalESMO Open
Issue number1
StatePublished - Feb 2023

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this